Diagnosis and treatment of cognitive impairment
- PMID: 31161337
- DOI: 10.1007/s00391-019-01560-0
Diagnosis and treatment of cognitive impairment
Abstract
As a result of the aging population dementia is a growing challenge, especially in healthcare. Nevertheless, cognitive disorders are often not systematically evaluated, especially during hospital stays for other reasons; however, cognitive impairment is associated with a number of geriatric syndromes, including falls, delirium, dysphagia and lack of adherence to treatment plans. This article considers the current state of diagnosis and treatment of dementia. Non-pharmacological therapeutic approaches as well as current and future pharmacological treatment options are discussed. The drugs of choice for the symptomatic treatment of cognitive deficits in Alzheimer's disease and Parkinson-associated dementia are cholinesterase inhibitors and memantine; there is no specific pharmacological treatment for other types of dementia. Prevention and treatment of cardiovascular risk factors can potentially retard the progression of possibly all forms of dementia.
Keywords: Alzheimer disease; Antidementia agents; Dementia; Imaging; Prevention.
Similar articles
-
Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.Drugs Aging. 2016 Jul;33(7):451-60. doi: 10.1007/s40266-016-0372-3. Drugs Aging. 2016. PMID: 27154396
-
[Drug treatment of Alzheimer's dementia : Status quo and perspectives].Internist (Berl). 2019 Jul;60(7):761-768. doi: 10.1007/s00108-019-0625-4. Internist (Berl). 2019. PMID: 31139854 Review. German.
-
Pharmacological treatment of dementia and mild cognitive impairment due to Alzheimer's disease.Curr Opin Psychiatry. 2011 Nov;24(6):556-61. doi: 10.1097/YCO.0b013e32834b7b96. Curr Opin Psychiatry. 2011. PMID: 21934621 Review.
-
[Therapy of Dementia: State of the Art].Dtsch Med Wochenschr. 2018 May;143(10):741-747. doi: 10.1055/s-0043-113619. Epub 2018 May 4. Dtsch Med Wochenschr. 2018. PMID: 29727890 German.
-
Pharmacological treatment of dementia.Curr Opin Psychiatry. 2012 Nov;25(6):542-50. doi: 10.1097/YCO.0b013e328358e4f2. Curr Opin Psychiatry. 2012. PMID: 22992546 Review.
Cited by
-
microRNA-Based Biomarkers in Alzheimer's Disease (AD).Front Neurosci. 2020 Oct 30;14:585432. doi: 10.3389/fnins.2020.585432. eCollection 2020. Front Neurosci. 2020. PMID: 33192270 Free PMC article. Review.
-
Delirium after Cardiac Surgery-A Narrative Review.Brain Sci. 2023 Dec 7;13(12):1682. doi: 10.3390/brainsci13121682. Brain Sci. 2023. PMID: 38137130 Free PMC article. Review.
-
Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.Med Sci Monit. 2021 Jan 25;27:e930886. doi: 10.12659/MSM.930886. Med Sci Monit. 2021. PMID: 33487628 Free PMC article.
-
A Novel Concept is Needed for Combating Alzheimer's Disease and NeuroHIV.Alzheimers Dis Dement. 2020 Aug 19;4(1):85-91. doi: 10.36959/734/377. Alzheimers Dis Dement. 2020. PMID: 32968718 Free PMC article.
-
Protective Role of Electroacupuncture Against Cognitive Impairment in Neurological Diseases.Curr Neuropharmacol. 2025;23(2):145-171. doi: 10.2174/1570159X22999240209102116. Curr Neuropharmacol. 2025. PMID: 38379403 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials